{
    "organizations": [],
    "uuid": "6b4a751f4172c350e600276a1193d16e6cc75b7a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gtx-announces-early-completion-of/brief-gtx-announces-early-completion-of-patient-enrollment-in-the-astrid-trial-idUSASC09V7T",
    "ord_in_thread": 0,
    "title": "BRIEF-GTX Announces Early Completion Of Patient Enrollment In The Astrid Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9 (Reuters) - GTX Inc:\n* GTX ANNOUNCES EARLY COMPLETION OF PATIENT ENROLLMENT IN THE ASTRID TRIAL, A PHASE 2 CLINICAL TRIAL OF ENOBOSARM IN STRESS URINARY INCONTINENCE\n* CONTROLLED CLINICAL TRIAL EXPECTED EARLY IN Q4 OF 201 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-09T19:24:00.000+03:00",
    "crawled": "2018-04-09T14:44:30.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "gtx",
        "inc",
        "gtx",
        "announces",
        "early",
        "completion",
        "patient",
        "enrollment",
        "astrid",
        "trial",
        "phase",
        "clinical",
        "trial",
        "enobosarm",
        "stress",
        "urinary",
        "incontinence",
        "controlled",
        "clinical",
        "trial",
        "expected",
        "early",
        "q4",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}